Germany
Japan
United Kingdom
China
Rabbit monoclonal anti-Sox2 Antibody, clone OTIR102D11
| Applications | WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
Antibodies
View as table Download
Rabbit monoclonal anti-Sox2 Antibody, clone OTIR094F2
| Applications | WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
Rabbit monoclonal anti-Sox2 Antibody, clone OTIR102D11
| Applications | WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
Rabbit monoclonal anti-ERK3 antibody for SISCAPA, clone OTIR5F3
| Applications | SISCAPA |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
Rabbit polyclonal Bi-Phospho-ERK1/2(T202/Y204) Antibody
| Applications | Dot, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | This ERK1/2 Antibody is generated from rabbits immunized with a KLH conjugated synthetic phosphopeptide corresponding to amino acid residues surrounding T202/Y204 of human ERK1/2. |
| Modifications | Phospho-specific |
Rabbit Polyclonal Anti-ACTB Antibody
| Applications | IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | Synthetic peptide of human ACTB |
TA349205 is a possible alternative to TA349208.
USD 524.00
In Stock
Rabbit anti-VEGFR (Phospho-Tyr951) polyclonal antibody (Phospho-specific)
| Applications | IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized phosphopeptide derived from humanVEGFR2 around the phosphorylation site of tyrosine 951 (K-D-YP-V-G). |
| Modifications | Phospho-specific |
Goat Polyclonal Anti-CD45 Antibody
| Applications | WB |
| Reactivities | Canine, Human, Monkey, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | Purified recombinant peptide derived from within residues 1,260 aa to the C-terminus of human CD45 produced in E. coli. |
Goat Polyclonal Anti-VEGFR2 Antibody
| Applications | WB |
| Reactivities | Canine, Human, Mouse |
| Conjugation | Unconjugated |
| Immunogen | Purified recombinant peptide derived from the N-terminus (residues 20-125 aa) of human VEGFR2 produced in E. coli. |
Goat Polyclonal Anti-CD4 Antibody
| Applications | WB |
| Reactivities | Canine, Human, Monkey, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | Purified recombinant peptide derived from within 50 to 235 aa, corresponding to the external domain of human CD4 produced in E. coli. |
Rabbit polyclonal Neuro D (Ser274) antibody(Phospho-specific)
| Applications | WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized phosphopeptide derived from human Neuro D around the phosphorylation site of serine 274 (P-L-SP-P-P). |
| Modifications | Phospho-specific |
Rabbit Polyclonal CD44 (Ser706) Antibody (Phospho-specific)
| Applications | WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against A synthesized peptide derived from human CD44 around the phosphorylation site of Serine 706 |
| Modifications | Phospho-specific |
Goat Polyclonal Anti-CD31 Antibody
| Applications | WB |
| Reactivities | Canine, Human, Monkey, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | Purified recombinant peptide within residues 690 aa to the C-terminus of human CD31 produced in E. coli. |
Rabbit polyclonal Catenin-beta (Tyr489) antibody(Phospho-specific)
| Applications | IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized phosphopeptide derived from human Catenin-β around the phosphorylation site of tyrosine 489 (L-H-YP-G-L). |
| Modifications | Phospho-specific |
Goat Polyclonal Anti-CDH1 Antibody
| Applications | WB |
| Reactivities | Canine, Human, Monkey, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | Purified Recombinant peptide derived from within residues 601 to 701 of human CDH1 produced in E. coli. |
Rabbit Polyclonal Antibody against SOX2 - Embryonic Stem Cell Marker
| Applications | FC, IHC, WB |
| Reactivities | Human, Mouse, Sheep |
| Conjugation | Unconjugated |
| Immunogen | A synthetic peptide made to the N-terminal region of human SOX2 protein (within residues 1-100). [Swiss-Prot# P48431] |
Rabbit polyclonal KLF5 Antibody (C-term)
| Applications | FC, IF, IHC, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | This KLF5 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 341-370 amino acids from the C-terminal region of human KLF5. |
Rabbit Polyclonal STAT5A (Ser780) Antibody (Phospho-specific)
| Applications | WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against A synthesized peptide derived from human STAT5A around the phosphorylation site of Serine 780 |
| Modifications | Phospho-specific |
Rabbit Polyclonal STAT5A/B (Ser725/730) Antibody (Phospho-specific)
| Applications | WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against A synthesized peptide derived from human STAT5A/B around the phosphorylation site of Serine 725/730 |
| Modifications | Phospho-specific |
Goat Polyclonal Antibody against Tafazzin
| Applications | WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | Peptide with sequence C-HLKTQAEQLHNH, from the C Terminus of the protein sequence according to NP_000107.1; NP_851828.1; NP_851829.1; NP_851830.1. |
Rabbit Polyclonal GATA3 Antibody
| Applications | IF, IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | GATA3 antibody was raised against a 17 amino acid synthetic peptide near the carboxy terminus of human GATA3. The immunogen is located within amino acids 340 - 390 of GATA3. |
Rabbit anti-STAT5A (Phospho-Tyr694) polyclonal antibody (Phospho-specific)
| Applications | IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized phosphopeptide derived from humanSTAT5A around the phosphorylation site of tyrosine 694 (D-G-YP-V-K). |
| Modifications | Phospho-specific |
Phospho-KDR-Y1175 Rabbit Polyclonal Antibody
| Applications | WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | A phospho specific peptide corresponding to residues surrounding Y1175 of human KDR |
| Modifications | Phospho-specific |
Active filters
Category
-
Antibodies
- Primary Antibodies
Reactivities
- Mouse
Isotypes
- IgG
Families
- ES Cell Differentiation/IPS
Availabilities
- In Stock
Filter by
Target Symbol
- AKT1 (18)
- EGFR (18)
- JUN (14)
- SRC (10)
- CTNNB1 (8)
- PRKCA (8)
- STAT5A (8)
- GAPDH (7)
- MAPK3 (7)
- RUNX1 (7)
- SMAD1 (7)
- SOX2 (7)
- BCL2L1 (6)
- CASP3 (6)
- PDGFRB (6)
- SMAD3 (6)
- STAT5B (6)
- CD44 (5)
- CEBPA (5)
- GCG (5)
- HNF1B (5)
- MAPK8 (5)
- MYB (5)
- TNNI3 (5)
- ACTB (4)
- CDH1 (4)
- GATA1 (4)
- GATA3 (4)
- GATA4 (4)
- KDR (4)
- KIT (4)
- PTPRC (4)
- SMAD2 (4)
- SP1 (4)
- ACE (3)
- ACTN1 (3)
- AKT2 (3)
- CCR5 (3)
- CDX2 (3)
- CSNK1A1 (3)
- HCRTR1 (3)
- ID4 (3)
- ITGB3 (3)
- MAPK6 (3)
- NOTCH1 (3)
- TUBB3 (3)
- VIM (3)
- YBX1 (3)
- A1BG (2)
- AKT3 (2)
- ALCAM (2)
- ALDH1A1 (2)
- ANGPT1 (2)
- ANPEP (2)
- BCL2 (2)
- BDNF (2)
- CD93 (2)
- CDCA4 (2)
- CEBPB (2)
- CSNK2A1 (2)
- CYP3A4 (2)
- DKK2 (2)
- EGF (2)
- FGF7 (2)
- FLT3 (2)
- FN1 (2)
- FOXA2 (2)
- GATA6 (2)
- GFAP (2)
- ID2 (2)
- IL2RA (2)
- INS (2)
- ITGA4 (2)
- ITGA6 (2)
- ITGB1 (2)
- KLF5 (2)
- MAP2 (2)
- NKX2-1 (2)
- PDGFRA (2)
- PDX1 (2)
- PECAM1 (2)
- PLAU (2)
- SERPINA1 (2)
- SFRP1 (2)
- SHH (2)
- SMAD5 (2)
- SMO (2)
- SOX1 (2)
- SOX7 (2)
- SOX9 (2)
- STAT6 (2)
- TCF3 (2)
- TEK (2)
- ABCB1 (1)
- ACVR1 (1)
- ANGPTL2 (1)
- APH1A (1)
- AXIN1 (1)
- AXIN2 (1)
- BGLAP (1)
Applications
Antibody Hosts
Clonalities
Conjugates
Modifications
Pathways
- Pathways in cancer (185)
- Focal adhesion (135)
- Colorectal cancer (108)
- ErbB signaling pathway (103)
- MAPK signaling pathway (99)
- Prostate cancer (74)
- Pancreatic cancer (73)
- Melanoma (70)
- Adherens junction (69)
- Acute myeloid leukemia (67)
- Endometrial cancer (67)
- Glioma (67)
- Regulation of actin cytoskeleton (67)
- Wnt signaling pathway (67)
- Chronic myeloid leukemia (64)
- GnRH signaling pathway (63)
- Non-small cell lung cancer (59)
- Tight junction (58)
- Gap junction (57)
- Neurotrophin signaling pathway (55)
- Epithelial cell signaling in Helicobacter pylori infection (54)
- VEGF signaling pathway (53)
- Cytokine-cytokine receptor interaction (52)
- Jak-STAT signaling pathway (52)
- T cell receptor signaling pathway (52)
- Toll-like receptor signaling pathway (51)
- Endocytosis (49)
- Renal cell carcinoma (47)
- B cell receptor signaling pathway (45)
- Fc epsilon RI signaling pathway (45)
- Fc gamma R-mediated phagocytosis (44)
- Chemokine signaling pathway (41)
- TGF-beta signaling pathway (41)
- Insulin signaling pathway (40)
- Small cell lung cancer (40)
- Progesterone-mediated oocyte maturation (39)
- Apoptosis (38)
- Leukocyte transendothelial migration (37)
- Melanogenesis (35)
- Calcium signaling pathway (34)
- mTOR signaling pathway (33)
- Adipocytokine signaling pathway (31)
- Bladder cancer (31)
- Hematopoietic cell lineage (31)
- Arrhythmogenic right ventricular cardiomyopathy (ARVC) (30)
- Cell adhesion molecules (CAMs) (30)
- Pathogenic Escherichia coli infection (29)
- Dorso-ventral axis formation (28)
- Natural killer cell mediated cytotoxicity (25)
- Hypertrophic cardiomyopathy (HCM) (24)
- Basal cell carcinoma (22)
- Alzheimer's disease (21)
- Dilated cardiomyopathy (21)
- Thyroid cancer (21)
- ECM-receptor interaction (20)
- Type II diabetes mellitus (18)
- Metabolic pathways (16)
- Long-term depression (15)
- Long-term potentiation (15)
- Vascular smooth muscle contraction (15)
- Amyotrophic lateral sclerosis (ALS) (14)
- Hedgehog signaling pathway (14)
- Maturity onset diabetes of the young (14)
- NOD-like receptor signaling pathway (13)
- Viral myocarditis (13)
- Huntington's disease (12)
- Prion diseases (12)
- Vibrio cholerae infection (12)
- Axon guidance (11)
- Cell cycle (10)
- Oocyte meiosis (9)
- Phosphatidylinositol signaling system (9)
- Glycolysis / Gluconeogenesis (8)
- Notch signaling pathway (8)
- Parkinson's disease (6)
- RIG-I-like receptor signaling pathway (6)
- Renin-angiotensin system (6)
- p53 signaling pathway (6)
- Cardiac muscle contraction (5)
- Primary immunodeficiency (5)
- Systemic lupus erythematosus (5)
- Complement and coagulation cascades (4)
- Neuroactive ligand-receptor interaction (4)
- Retinol metabolism (4)
- Antigen processing and presentation (3)
- Autoimmune thyroid disease (3)
- Type I diabetes mellitus (3)
- Allograft rejection (2)
- Drug metabolism - cytochrome P450 (2)
- Drug metabolism - other enzymes (2)
- Glutathione metabolism (2)
- Linoleic acid metabolism (2)
- Metabolism of xenobiotics by cytochrome P450 (2)
- Regulation of autophagy (2)
- Tyrosine metabolism (2)
- ABC transporters (1)
- Asthma (1)
- Citrate cycle (TCA cycle) (1)
- Cysteine and methionine metabolism (1)
- Graft-versus-host disease (1)
- Inositol phosphate metabolism (1)
- Lysosome (1)
- PPAR signaling pathway (1)
- Phenylalanine (1)
- Phenylalanine metabolism (1)
- Pyruvate metabolism (1)
- Ubiquinone and other terpenoid-quinone biosynthesis (1)
- Ubiquitin mediated proteolysis (1)
- tyrosine and tryptophan biosynthesis (1)